Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Risk-benefit considerations in the treatment of relapsing-remitting multiple sclerosis.
Does jcv antibody positivity encourage cessation of natalizumab therapy in multiple sclerosis?
Risk genes associated with pediatric-onset MS but not with monophasic acquired CNS demyelination.
Unusual symptoms and syndromes in multiple sclerosis.
Multiple sclerosis presenting initially with a worsening of migraine symptoms.
Mild phenotype of Charcot-Marie-Tooth disease type 4B1.
Diagnostic ability of a new method for measuring haemoglobin levels in the optic nerve head in multiple sclerosis patients.
Molecular grafting onto a stable framework yields novel cyclic peptides for the treatment of multiple sclerosis.
[New and emerging treatments for multiple sclerosis].
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Novel replication-competent circular DNA molecules from healthy cattle serum and milk and multiple sclerosis-affected human brain tissue.
Multiple sclerosis: Clinical characteristics and disability progression in Moroccan children.
Myelin and macrophages in the PNS: An intimate relationship in trauma and disease.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex(R)) in people with multiple sclerosis: a new approach.
Possible induction of acute disseminated encephalomyelitis (ADEM)-like demyelinating illness by intrathecal mesenchymal stem cell injection.
Critical role of activation induced cytidine deaminase in Experimental Autoimmune Encephalomyelitis.
Identification of Risk Factors for Falls in Multiple Sclerosis: A Systematic Review and Meta-Analysis.
Biosynthetic Assembly of the Bacteroides fragilis Capsular Polysaccharide A Precursor Bactoprenyl Diphosphate-Linked Acetamido-4-amino-6-deoxygalactopyranose.
Fingolimod for the treatment of relapsing multiple sclerosis.
VPAC2 (vasoactive intestinal peptide receptor type 2) receptor deficient mice develop exacerbated experimental autoimmune encephalomyelitis with increased Th1/Th17 and reduced Th2/Treg responses.
Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial.
A personalized, intense physical rehabilitation program improves walking in people with multiple sclerosis presenting with different levels of disability: a retrospective cohort.
ARP2/3 complex is required for directional migration of neural stem cell-derived oligodendrocyte precursors in electric fields.
[Diagnosis and treatment of pelvic disorders in patients with multiple sclerosis].

Pages